Toxicity after AAV delivery of RNAi expression constructs into nonhuman primate brain
出版年份 2021 全文链接
标题
Toxicity after AAV delivery of RNAi expression constructs into nonhuman primate brain
作者
关键词
-
出版物
NATURE MEDICINE
Volume 27, Issue 11, Pages 1982-1989
出版商
Springer Science and Business Media LLC
发表日期
2021-10-19
DOI
10.1038/s41591-021-01522-3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Adeno-Associated Virus Serotype-Specific Inverted Terminal Repeat Sequence Role in Vector Transgene Expression
- (2020) Lauriel F. Earley et al. HUMAN GENE THERAPY
- miR760 regulates ATXN1 levels via interaction with its 5′ untranslated region
- (2020) Larissa Nitschke et al. GENES & DEVELOPMENT
- Antisense Oligonucleotide Therapeutic Approach for Suppression of Ataxin-1 Expression: A Safety Assessment
- (2020) Brennon O’Callaghan et al. Molecular Therapy-Nucleic Acids
- Recent advances in molecular therapies for neurological disease: triplet repeat disorders
- (2019) Pedro Gonzalez-Alegre HUMAN MOLECULAR GENETICS
- Minimap2: pairwise alignment for nucleotide sequences
- (2018) Heng Li BIOINFORMATICS
- Adeno-associated Virus Genome Population Sequencing Achieves Full Vector Genome Resolution and Reveals Human-Vector Chimeras
- (2018) Phillip W.L. Tai et al. Molecular Therapy-Methods & Clinical Development
- RNAi prevents and reverses phenotypes induced by mutant human ataxin-1
- (2016) Megan S. Keiser et al. ANNALS OF NEUROLOGY
- Broad distribution of ataxin 1 silencing in rhesus cerebella for spinocerebellar ataxia type 1 therapy
- (2015) Megan S. Keiser et al. BRAIN
- shRNA-induced saturation of the microRNA pathway in the rat brain
- (2014) M A van Gestel et al. GENE THERAPY
- Broad Therapeutic Benefit After RNAi Expression Vector Delivery to Deep Cerebellar Nuclei: Implications for Spinocerebellar Ataxia Type 1 Therapy
- (2014) Megan S Keiser et al. MOLECULAR THERAPY
- Single nucleotide seed modification restores in vivo tolerability of a toxic artificial miRNA sequence in the mouse brain
- (2014) Alex Mas Monteys et al. NUCLEIC ACIDS RESEARCH
- RNAi or overexpression: Alternative therapies for Spinocerebellar Ataxia Type 1
- (2013) Megan S. Keiser et al. NEUROBIOLOGY OF DISEASE
- Altered Purkinje cell miRNA expression and SCA1 pathogenesis
- (2013) Edgardo Rodriguez-Lebron et al. NEUROBIOLOGY OF DISEASE
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- In vivo monitoring of recovery from neurodegeneration in conditional transgenic SCA1 mice
- (2011) Gülin Öz et al. EXPERIMENTAL NEUROLOGY
- Partial Loss of Ataxin-1 Function Contributes to Transcriptional Dysregulation in Spinocerebellar Ataxia Type 1 Pathogenesis
- (2010) Juan Crespo-Barreto et al. PLoS Genetics
- High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiency
- (2009) E Ayuso et al. GENE THERAPY
- Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial
- (2009) Albert M Maguire et al. LANCET
- Artificial MicroRNAs as siRNA Shuttles: Improved Safety as Compared to shRNAs In vitro and In vivo
- (2008) Ryan L Boudreau et al. MOLECULAR THERAPY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started